Drugs / SCE-B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00592839 | Dec 2007 → Feb 2009 | — | Duramed Research | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCE-B | “0.3 mg or 0.625 mg SCE-B tablets daily plus matching placebo” NCT00592839 ↗ |
| Route | Oral | “two doses of oral synthetic conjugated estrogens-B tablets” PMID 22183214 ↗ Jan 2012 |